Skip to main content
. 2021 Jan 5;21(3):182. doi: 10.3892/etm.2021.9613

Table II.

Comparison of laboratory indexes between the asymptomatic-moderate group and the severe or above group.

Laboratory index Reference values Asymptomatic-moderate group (n=141) Severe or above (n=29) OR (95% CI) P-value
WBC (x109/l) 3.5-9.5 5.0±1.5 5.5±2.7 1.190 (0.937, 1.513) 0.154
Neur (%) 40.0-75.0 58.8±11.9 70.5±16.1 1.072 (1.026, 1.120) 0.002
Lymr (%) 20.0-50.0 30.4±11.1 21.1±12.6 0.935 (0.888, 0.985) 0.012
Monr (%) 3.0-8.0 9.6±3.2 7.5±3.7 0.762 (0.633, 0.916) 0.004
Neuc (x109/l) 1.8-6.3 3.0±1.3 4.1±2.8 1.375 (1.042, 1.815) 0.025
Lymc (x109/l) 1.1-3.2 1.5±0.7 1.0±0.5 0.300 (0.099, 0.911) 0.034
Monc (x109/l) 0.1-0.6 0.5±0.2 0.4±0.2 0.058 (0.003, 1.018) 0.051
RBC (x1012/l) Females, 3.8-5.1; males, 4.3-5.8 4.7±0.7 4.3±0.6 0.413 (0.148, 1.151) 0.091
HGB (g/l) Females, 115-150; males, 130-175 139.6±17.9 130.1±21.2 0.973 (0.946, 1.002) 0.066
HCT (%) Females, 35.0-45.0; males, 40.0-50.0 41.2±4.7 37.7±5.5 0.868 (0.775, 0.972) 0.014
PLT (x109/l) 125.0-350.0 184.3±58.5 173.9±56.5 1.006 (0.997, 1.015) 0.173
RDW (%) 11.5-14.9 13.1±1.9 13.6±2.8 1.191 (0.871, 1.629) 0.274
MPV (fl) 6.0-11.5 11.0±1.2 10.9±1.2 0.734 (0.467, 1.155) 0.182
PDW (fl) 15.5-18.1 14.8±3.2 15.3±2.1 0.980 (0.806, 1.192) 0.840
PTC (l/l) 0.108-0.272 0.2±0.1 0.2±0.1 0.904 (0.000, 10,957.021) 0.983
hsCRP (mg/l) 0.0-10.0 13.6±21.0 78.3±63.8 1.041 (1.020, 1.062) <0.001
PCT (ng/ml) 0.00-0.05 0.15±0.18 0.46±0.64 13.774 (1.399, 135.619) 0.025

Adjusted variables: Age, sex, hypertension, diabetes mellitus, cerebrovascular diseases, history of the tumor. OR, odds ratio; WBC, white blood cells; Neur, percentage of neutrophils; Lymr, percentage of lymphocytes; Monr, percentage of monocytes; Neuc, neutrophil count; Lymc, lymphocyte count; Monc, monocyte count; RBC, red blood cell count; HGB, hemoglobin; HCT, hematocrit, PLT, platelet count; RDW, red blood cell distribution width; MPV, mean platelet volume; PDW, platelet distribution width; PTC, plateletcrit; hsCRP, high-sensitivity C-reactive protein; PCT, procalcitonin.